Panakeia’s Post

A Massachusetts-based start-up uses biochemical reactions to visualize cancer and improve lumpectomies. Howard Hechler, CEO of Lumicell, recognizes the constraints of current techniques and presents the start-up’s solution LumiSystem, a combination of the imaging agent LUMISIGHT and Lumicell Direct Visualization System (DVS), as a way to detect #cancer that otherwise would go undetected. Here's how Lumicell is shedding light on residual cancer: https://bit.ly/4fI4fuU #medtech #medicaldevices #startups  

It's his life's mission to get more folks to screen for cancer early. As the founding CEO of Biotech startup Lucence, Dr Min-Han Tan is tapping on his previous experience as a doctor and scientist, blazing the trail as the first Asian-headquartered startup for cancer testing to obtain Medicare coverage in the US. #TechItFromMe   ⬇️ Watch the video to find out more about how he did it.

October is here, and it's time to stand strong together for Breast Cancer Awareness Month. 🎗️ Let’s raise our voices, share stories, and support those battling breast cancer. Early detection saves lives—spread the word, get screened, and stay strong. Together, we can make a difference. #BreastCancerAwareness #ThinkPink #FightForACure #itwp #business #technology #informationtechnology #startup #smallbusiness #minorityinIT #diversityintech #innovation #ITservices #womeninbusiness #blackownedbusiness #womenintech #womanowned #blackowned #veteranowned #entrepreneurship #tech #techie #woc #dei #veteran

What is the latest in the efforts to beat cancer? New treatment modalities are emerging in our fight against an enemy that hides, morphs and adapts. But thanks to the great research of many, we are making significant progress. Thanks to Rob Lavine for sitting with several of us in the field to discuss thoughts for this article. Rakhshita Dhar, Anne Horgan (nee Nguyen), Hakan Goker, Mayo Clinic Ventures, Geoff Johnson, MD, PhD, Norman Sharpless, Justin Butler, James Rogers, Peter Noseworthy, MD,Clark Otley, Andy Danielsen, Jolene Summer Bolster, Vijay Shah, Charles Conroy, RPh, MBA #cancer, #pathology, #AI, #artificialintelligence, #radiopharma, #radioligand, #radiation, #antibody, #therapy, #therapeutic, #venture, #capital, #innovation, #technology, #technologytransfer, #drug, #investment, #biologic, #fund, #research, #digitalpathology, #conjugate, Andy Walter, Sami Yusuf, PharmD,MS,MBA

🚀 Thrilled to share that Oncoliq’s groundbreaking journey is featured in Venture Capital Post! 🚀 Cancer continues to claim millions of lives, often due to late-stage diagnoses. At Oncoliq, we’re determined to change this through our scalable, decentralized microRNA detection technology—bringing the power of early cancer detection to communities worldwide. This article reveals the depth of our mission and the steps we’re taking to reduce global cancer mortality. As we accelerate our growth, we’re eager to connect with visionary investors and partners ready to make an impact. 👉 Don’t miss the full story here: Life-Saving Tech: Oncoliq's Scalable, Decentralized Solution to Reduce Cancer Mortality https://lnkd.in/ddxKA5gJ Join us if you're interested in being part of this life-saving innovation journey. Together, we can drive real change. #Oncoliq #Biotechnology #CancerDetection #HealthTech #Innovation #StartupFunding #VentureCapital #BusinessGrowth #EarlyDetection

🎉 Thrilled to share that Oncoliq has been featured in a Venture Capital Post article! 🚀 As we focus on launching our product by early 2026, we want to keep sharing the importance of early detection in significantly improving survival rates. Current screening methods are inaccessible to many or not sensitive enough to catch cancers early 👩🔬🏥. Oncoliq's groundbreaking blood test detects microRNA, tiny molecules in the early stages of tumor development. This is precisely what differentiates us from competitors who rely on detecting ctDNA, which only appears in the bloodstream during later stages of cancer. "At Oncoliq, we've developed a solution that can change the landscape of cancer diagnostics, making it possible to detect cancer early, easily, and at a low cost," says Marina Simian, to the Venture Capital Post team. 🚀 Join Oncoliq if you feel inspired about shaping the future of cancer detection and saving lives! Read the full article here and comment your thoughts!👉 https://lnkd.in/ddxKA5gJ Thank you [Venture Capital Post] #Oncoliq #Biotechnology #EarlyDetection #LiquidBiopsy #HealthTech #InnovationInHealthcare #VentureCapital #HealthcareInvesting #CancerDiagnosis #CancerMortality #HealthStartups

Check out the recent interview by our scientific founder, 𝗣𝗿𝗼𝗳. 𝗗𝗿. Philipp Jost, in the latest edition of the #MEDitio where he talks about the dynamic startup ecosystem emerging at the 𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙎𝙘𝙞𝙚𝙣𝙘𝙚 𝘾𝙞𝙩𝙮 𝙂𝙧𝙖𝙯 and highlights the reason why Cycuria chose to establish roots in this growing hub for biotech and healthcare innovation. Thank you to #MEDitio for spotlighting our vision and our commitment to making a real impact in oncology. Stay tuned as we continue pushing boundaries in the fight against cancer! 🌐 #CycuriaTherapeutics #OncologyInnovation #MedicalScienceCityGraz #Biotech #CancerResearch

Can AI transform cancer diagnostics and treatment on a global scale? In Episode Two of Startup Insider, a new series from Startup Daily and Dell Technologies, the founders of NanoCube Health – Lisa Milani and Dr Shawn Goussous – test the limits of what’s possible and attract interest from abroad. Watch the four-part series here: https://lnkd.in/ga2MJSAc

Hemerion Therapeutics was just listed within one of the Top 100 start-ups worth investing in. I could not agree more. What's more and needs to be stressed: Hemerion is pushing the limits and venturing into entirely novel grounds as regards therapeutic modality and treatment approach for #glioblastoma, a devastating disease with very bad outcome prognosis, highest relapse-rates, and close to no reasonable therapeutic options available when it comes to efficacy criteria. Invest now. Further info via the article below: https://lnkd.in/eHuATvGk #cancer #therapy #innovation #startup #venture #invest #clinicalimpact

This is the future of FemTech 🌟 We're absolutely thrilled to celebrate Feminai's remarkable team making it onto Forbes Israel's 30Under30 list! Their patented technology saves lives, providing home tests for early breast cancer detection backed by AI. Nothing beats seeing your portfolio teams (who just finished our accelerator program) get the recognition they deserve. We're proud to be their pre-seed investors and witness the company's journey start in such a promising way. Read all about their phenomenal journey - Link in the comments below Guy Katsovich | Yair Vardi #portfoliocompany